Esperion Therapeutics
ESPR
#6816
Rank
C$0.62 B
Marketcap
$3.17
Share price
8.06%
Change (1 day)
160.99%
Change (1 year)

Esperion Therapeutics (ESPR) - Total debt

Total debt on the balance sheet as of June 2024 : C$0.37 Billion

According to Esperion Therapeutics's latest financial reports the company's total debt is C$0.37 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Esperion Therapeutics - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2023-12-31C$0.35 B-0.3%
2022-12-31C$0.35 B6.78%
2021-12-31C$0.33 B40.27%
2020-12-31C$0.23 B11480.85%
2019-12-31C$2.04 M
2018-12-31N/A-100%
2017-12-31C$1.31 M-64.2%
2016-12-31C$3.67 M-38.36%
2015-12-31C$5.95 M5.37%
2014-12-31C$5.65 M
2012-12-31C$22.64 M222.73%
2011-12-31C$7.01 M
2002-12-31C$13.88 M37.38%
2001-12-31C$10.1 M81.17%
2000-12-31C$5.57 M39.2%
1999-12-31C$4 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$52.09 M-86.08%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.83 B 123.93%๐Ÿ‡บ๐Ÿ‡ธ USA
C$95.51 B 25,417.68%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.76 B 904.70%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.61 B 64.99%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.14 B-62.55%๐Ÿ‡บ๐Ÿ‡ธ USA